BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wall CM, Charlett A, Caygill CP, Gatenby PA, Ramus JR, Winslet MC, Watson A. Are newly diagnosed columnar-lined oesophagus patients getting younger? Eur J Gastroenterol Hepatol 2009;21:1127-31. [PMID: 19295439 DOI: 10.1097/MEG.0b013e328329c414] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Wang SE, Kendall BJ, Hodge AM, Dixon-Suen SC, Dashti SG, Makalic E, Williamson EM, Thomas RJS, Giles GG, English DR. Demographic and lifestyle risk factors for gastroesophageal reflux disease and Barrett's esophagus in Australia. Dis Esophagus 2022;35:doab058. [PMID: 34409990 DOI: 10.1093/dote/doab058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Gatenby P, Bhattacharjee S, Wall C, Caygill C, Watson A. Risk stratification for malignant progression in Barrett’s esophagus: Gender, age, duration and year of surveillance. World J Gastroenterol 2016; 22(48): 10592-10600 [PMID: 28082811 DOI: 10.3748/wjg.v22.i48.10592] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
3 Coleman HG, Bhat SK, Murray LJ. Epidemiology and prevalence of Barrett's esophagus. Esophageal cancer and barrett's esophagus 2015. [DOI: 10.1002/9781118655153.ch3] [Reference Citation Analysis]
4 Gatenby P, Caygill C, Wall C, Bhatacharjee S, Ramus J, Watson A, Winslet M. Lifetime risk of esophageal adenocarcinoma in patients with Barrett's esophagus. World J Gastroenterol 2014; 20(28): 9611-9617 [PMID: 25071359 DOI: 10.3748/wjg.v20.i28.9611] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
5 Jo HJ, Lee HS, Kim N, Nam RH, Chang H, Kim MS, Kim SE, Oh JC, Lee DH, Jung HC. Predictable Marker for Regression of Barrett's Esophagus by Proton Pump Inhibitor Treatment in Korea. J Neurogastroenterol Motil 2013;19:210-8. [PMID: 23667752 DOI: 10.5056/jnm.2013.19.2.210] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
6 Milind R, Attwood SE. Natural history of Barrett's esophagus. World J Gastroenterol 2012; 18(27): 3483-3491 [PMID: 22826612 DOI: 10.3748/wjg.v18.i27.3483] [Cited by in CrossRef: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
7 den Hoed CM, van Blankenstein M, Dees J, Kuipers EJ. The minimal incubation period from the onset of Barrett’s oesophagus to symptomatic adenocarcinoma. Br J Cancer. 2011;105:200-205. [PMID: 21673678 DOI: 10.1038/bjc.2011.214] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
8 Coleman HG, Bhat S, Murray LJ, McManus D, Gavin AT, Johnston BT. Increasing incidence of Barrett’s oesophagus: a population-based study. Eur J Epidemiol. 2011;26:739-745. [PMID: 21671079 DOI: 10.1007/s10654-011-9596-z] [Cited by in Crossref: 82] [Cited by in F6Publishing: 64] [Article Influence: 7.5] [Reference Citation Analysis]